Forte Biosciences, Inc. (FBRX) NASDAQ
18.18
-1.065(-5.54%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
18.18
-1.065(-5.54%)
Currency In USD
| Market Cap | 4.01B |
| Enterprise Value | 3.94B |
| P/E Ratio | -42.74 |
| PEG Ratio | -0.44 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 77.01 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -2.55 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -1.13 |
| Return On Equity | -1.06 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -64,000 |
| EBITDA | -70.59M |
| Net Income | -69.38M |
| Diluted EPS | -4.71 |
| Total Cash | 58.22M |
| Total Cash/Share | 0.33 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 2.75 |
| Book Value Per Share | 0.24 |
| 52-Week Change | 105.83 |
| 52-Week High | 35.8 |
| 52-Week Low | 9.1 |
| Moving Average 50 Days | 26.2 |
| Moving Average 200 Days | 21.98 |
| Average Volume | 286,380 |
| Shares Outstanding | 13.89M |
| % Held by Institutions | 9.19 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:25 |
| Last Split Date | August 28, 2024 |